KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemed (CHE) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Chemed (CHE) over the last 16 years, with Q3 2025 value amounting to $2.6 million.

  • Chemed's Interest & Investment Income fell 3034.35% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year decrease of 2985.22%. This contributed to the annual value of $14.6 million for FY2024, which is 13301.44% up from last year.
  • As of Q3 2025, Chemed's Interest & Investment Income stood at $2.6 million, which was down 3034.35% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Chemed's Interest & Investment Income ranged from a high of $4.2 million in Q1 2024 and a low of $57000.0 during Q3 2021
  • In the last 5 years, Chemed's Interest & Investment Income had a median value of $154000.0 in 2022 and averaged $1.5 million.
  • As far as peak fluctuations go, Chemed's Interest & Investment Income tumbled by 8652.48% in 2021, and later skyrocketed by 498507.46% in 2023.
  • Quarter analysis of 5 years shows Chemed's Interest & Investment Income stood at $89000.0 in 2021, then dropped by 24.72% to $67000.0 in 2022, then skyrocketed by 4985.07% to $3.4 million in 2023, then dropped by 5.93% to $3.2 million in 2024, then dropped by 20.28% to $2.6 million in 2025.
  • Its Interest & Investment Income stands at $2.6 million for Q3 2025, versus $2.6 million for Q2 2025 and $2.1 million for Q1 2025.